First-in-human novel bispecific epitope anti-CD5 nanobody CAR-T cells for refractory or relapsed T-cell malignancies.

Autologous CD5 CAR T-cells - Beijing GoBroad Hospital

https://www.asco.org/abstracts-presentations/261312/

Lu Haiyang; Su Li; Yuxuan Song; Chuanhe Jiang; Jing Pan; Xiaoxia Hu

Apr 21, 2026